GEODE CAPITAL MANAGEMENT, LLC - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 102 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,512,202
-38.3%
1,037,946
+10.7%
0.00%0.0%
Q2 2023$8,933,873
+0.5%
937,447
+16.0%
0.00%0.0%
Q1 2023$8,892,040
+77014.2%
808,367
+3.8%
0.00%
-50.0%
Q4 2022$11,531
-99.9%
779,144
+6.1%
0.00%0.0%
Q3 2022$14,031,000
+15.8%
734,244
+29.1%
0.00%0.0%
Q2 2022$12,118,000
+23.5%
568,666
+11.6%
0.00%
+100.0%
Q1 2022$9,810,000
-3.3%
509,381
+4.1%
0.00%0.0%
Q4 2021$10,148,000
-13.1%
489,344
+0.1%
0.00%
-50.0%
Q3 2021$11,678,000
-9.9%
488,855
+2.9%
0.00%0.0%
Q2 2021$12,961,000
+3.8%
474,967
+10.0%
0.00%0.0%
Q1 2021$12,490,000
+31.3%
431,758
+27.7%
0.00%0.0%
Q4 2020$9,512,000
+31.0%
338,152
+36.4%
0.00%
+100.0%
Q3 2020$7,263,000
+57.8%
247,913
+62.8%
0.00%0.0%
Q2 2020$4,604,000
+155.9%
152,262
+152.2%
0.00%
Q1 2020$1,799,00060,3800.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$46,113,2723.06%
Pivotal bioVenture Partners Investment Advisor LLC 1,105,309$5,869,1912.34%
Bain Capital Life Sciences Investors, LLC 3,000,000$15,930,0001.78%
Sio Capital Management, LLC 635,969$3,376,9951.04%
Rubric Capital Management LP 5,034,530$26,733,3541.00%
Tejara Capital Ltd 309,179$1,641,7400.93%
AlphaCentric Advisors LLC 165,000$876,1500.50%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,135,227$6,028,0550.33%
Orbimed Advisors 1,914,479$10,165,8830.22%
Two Seas Capital LP 164,807$875,1250.18%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders